Solomon also collaborated in international research studies, including a multi-country HIV/STD Prevention Trial at the US National Institute of Mental Health, the HIV Prevention Trials Network run by the US National Institute of Allergy and Infectious Diseases, an NIH study of the HIV stigma in health care settings in Southern India, and a Phase III study of 6% CS GEL, a candidate microbicide of CONRAD (organization).[1][14]